Viewing Study NCT00226668


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-01-05 @ 5:09 PM
Study NCT ID: NCT00226668
Status: WITHDRAWN
Last Update Posted: 2008-01-03
First Post: 2005-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
Sponsor: Celtic Pharma Development Services
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-01
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2008-01
Completion Date Type: ESTIMATED
First Submit Date: 2005-09-23
First Submit QC Date: None
Study First Post Date: 2005-09-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2007-12-27
Last Update Post Date: 2008-01-03
Last Update Post Date Type: ESTIMATED